- Drug discoverer and developer Sareum Holdings said it expected to swing to a full-year loss as it progressed its development programme.

Net losses for the year through June were expected to be £1.47m, compared to a profit of £400k on-year, the company said in a trading statement.

Cash at bank at 30 June was £1.38m.

Sareum said it would release its audited full-year results by mid-October.

At 9:21am: [LON:SAR] Sareum Holdings PLC share price was 0p at 0.73p

Story provided by